Study of Vemurafenib, Carboplatin, and Paclitaxel

NCT01636622 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancers

Interventions

DRUG: Vemurafenib
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

M.D. Anderson Cancer Center